Health Care • Medical/Nursing Services
$31.83 ▼ -0.02
(-0.06%)
MKT CAP: $4.77B • VOL: 4.23M
52W L $18 52W H $37
OPCH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.65B | $5.00B | $4.30B |
| YoY Revenue Growth % | +13.0% | +16.2% | — |
| Gross Profit | $1.09B | $1.01B | — |
| Gross Margin % | 19.3% | 20.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $337.9M | $321.8M | $314.6M |
| Operating Margin % | 6.0% | 6.4% | 7.3% |
| Net Income (GAAP) | $207.6M | $211.8M | $267.1M |
| EBITDA (Normalized) | $371.0M | $350.3M | $469.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $258.4M | $323.4M | $371.3M |
| Capital Expenditures (CapEx) | $41.3M | $35.6M | $193.6M |
| Free Cash Flow (FCF) | $217.1M | $287.8M | $177.7M |
| FCF Margin % | 3.8% | 5.8% | 4.1% |
| Return on Invested Capital (ROIC %) | 11.9% | 12.1% | 8.0% |
| Cash & Short-Term Equivalents | $232.6M | $412.6M | — |
| Total Debt (Short + Long Term) | $1.15B | $1.10B | $1.21B |
| Total Stockholders' Equity | $1.33B | $1.40B | $2.48B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR OPCH.